Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
Health & Biotech
Link copied to
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim catches up with Daniel Kenny, Chief Executive Officer at OncoSil Medical (ASX: OSL).
The company has performed impressively in the wake of a massive regulatory setback, regaining much of its lost share price value.
So click below to hear about the company’s impressive 2020 performance, treatment approval progress and plans for the year ahead.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!